Why does CFU quantification matter for target validation in antimicrobial discovery?

CFU quantification measures viable intracellular bacteria that have evaded host defenses, providing a direct functional readout of pathogen survival. This enables target validation by linking genetic or chemical perturbations to a clinically relevant phenotype—intracellular replication. The assay supports mechanistic de-risking by confirming whether a candidate impacts a key virulence trait essential for disease progression.

How does gentamicin treatment enable isolation of the intracellular bacterial variable in the CFU assay?

Gentamicin selectively eliminates extracellular bacteria while preserving those internalized by macrophages, isolating the intracellular population as the dependent variable. This step ensures that CFU counts reflect only bacteria that have successfully invaded and replicated within host cells. By removing confounding extracellular signals, the assay enables accurate measurement of the infection phenotype relevant to target validation.

What quantitative dependent variable measurements does the CFU assay enable for hit evaluation?

The CFU assay enables counting of discrete bacterial colonies, each representing a viable unit derived from a single intracellular bacterium. This provides a quantitative dependent variable—colony-forming units per well—that can be compared across treatment conditions to assess compound effects on intracellular survival. The measurement supports statistical analysis and hit ranking in screening campaigns by delivering a linear, scalable readout of pathogen burden.

Why are replication requirements important for cross-functional collaboration in CFU-based assays?

Replication ensures that CFU measurements are consistent across experiments, operators, and laboratories, which is essential for reliable data sharing in multidisciplinary projects. Standardized protocols for infection, antibiotic treatment, lysis, and plating reduce variability and increase confidence in assay outputs. This reproducibility enables translational teams to trust in vitro results when advancing candidates to preclinical studies, aligning discovery and development efforts.

What statistical analysis capabilities are required before implementing the CFU assay in a screening workflow?

Implementation requires the ability to calculate mean CFU values, standard deviation, and statistical significance (e.g., via t-test or ANOVA) across replicate wells to detect meaningful differences between conditions. The assay generates count data that must be log-transformed if variance is unequal, enabling parametric testing for hit validation. These capabilities ensure that observed changes in intracellular bacterial survival are statistically robust and not due to experimental noise.

Quantification of Bacterial Infection in Host Cells by the Colony-Forming Unit Assay

JoVE Encyclopedia of Experiments

Immunology

0 views • 3:33 min • July 8th, 2025

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

To begin the colony-forming unit, or CFU, assay to quantify viable bacteria, take a multi-well plate containing cultured macrophages in growth media. Infect the macrophages with Listeria monocytogenes, a pathogenic bacteria capable of intracellular growth.

During infection, the macrophages engulf the bacteria, internalizing the bacteria within a membrane-bound compartment — a phagosome.

Bacteria secrete a pore-forming toxin and disrupt the phagosomal membrane. Thereby, the bacteria are allowed to enter the cytosol and replicate within the macrophages.

Briefly treat the infected macrophages with gentamicin, an antibiotic that selectively eliminates non-internalized bacteria while preserving intracellular bacteria.

Aspirate the overlying media containing antibiotics. Next, add sterile distilled water over the infected macrophages, creating a hypotonic environment. This leads to osmosis, where water molecules enter the cells and cause macrophage lysis, releasing the intracellular components, including the bacteria.

Spread the cell lysate containing intracellular bacteria onto the lysogeny agar plate, promoting the separation of individual bacterial cells and enabling their independent growth. During incubation, viable bacteria grow on the agar surface and form distinct colonies.

Count the colonies on the plate and obtain the CFU, representing intracellular bacteria that have evaded the host immune response and successfully replicated within the infected macrophages.

To harvest, slightly tilt the dish and carefully use a pipette to remove the entire media from the well. Add 0.5 milliliters of distilled sterile water to the well. After 30 seconds, transfer the resulting water lysate to a 1.5-milliliter microcentrifuge tube and vortex vigorously for 10 seconds.

Add 4.5 microliters and 50 microliters of the water lysate to 450 microliters of distilled sterile water to prepare the 10-fold and 100-fold dilutions. Briefly, vortex to ensure thorough mixing. Add 50 microliters of the original 10-fold diluted and 100-fold diluted samples onto lysogeny broth agar plates and spread using a plate spreader.

Related Videos

0 Views

Last updated: 1 August 2026

Quantification of Bacterial Infection in Host Cells by the Colony-Forming Unit Assay

Overview

Key Study Components

Area of Science

Background

Purpose of Study

Methods Used

Main Results

Conclusions

Frequently Asked Questions

Executive Industry Relevance

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

Screening & Assay Development

Translational & Preclinical Research

Pipeline & Workflow Integration

Operational & Enterprise Impact

Implementation Considerations

Biopharma FAQs

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Isolation of Salmonella typhimurium-containing Phagosomes from Macrophages

Counting Colony Forming Units (CFUs): Quantifying Bacteria from Fly Bodies

Quantification of Bacterial Load in Mouse Spleen and Liver After Systemic Infection

A Bacterial Infection Assay for Studying Anaerobic Bacteria-Host Cell Interactions

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

A Multi-well Format Polyacrylamide-based Assay for Studying the Effect of Extracellular Matrix Stiffness on the Bacterial Infection of Adherent Cells

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses